Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02585206 · ClinicalTrials.gov registry record · NA

Optimizing Text Messaging to Improve Adherence to Web-Based Cessation Treatment

A NA study, sponsored by Truth Initiative.

Completed
Registry status
NA
Development phase
1,485
Enrollment target

NCT02585206 is a NA study that has completed, run by Truth Initiative. The registered enrollment target is 1,485 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02585206, a NA study, has completed, sponsored by Truth Initiative.

COMPLETED
Registry status
NA
Development phase
1,485 participants
Enrollment target

Study Summary

This study is comprised of 2 phases to study the impact of a text message system on overall adherence to a web-based smoking cessation program. Phase I uses a full factorial design to identify the most optimal text message intervention to maximize adherence to the BecomeAnEX.org smoking cessation program. Phase II is a randomized controlled trial that compares regular BecomeAnEX users to those who will receive the optimized text message intervention (from Phase I) in conjunction with BecomeAnEX for impact on long-term abstinence.

Interventions

  • BEHAVIORAL Personalization
  • BEHAVIORAL Integration
  • BEHAVIORAL Dynamic Tailoring
  • BEHAVIORAL Message Intensity
  • BEHAVIORAL Optimal-Adherence Text

Trial Details

FieldValue
Enrollment Target 1,485 participants
Start Date 2018-03-29
Est. Completion 2020-07-10
Phase NA

Sponsor

Truth Initiative

9 total trials

What the Registry Record Tells You About NCT02585206

The ClinicalTrials.gov registry entry for NCT02585206 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,485 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Truth Initiative, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which Personalization is the first listed.

NCT02585206 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02585206 about?

NCT02585206 is a clinical study titled "Optimizing Text Messaging to Improve Adherence to Web-Based Cessation Treatment". This study is comprised of 2 phases to study the impact of a text message system on overall adherence to a web-based smoking cessation program. Phase I uses a full factorial design to identify the most optimal text message intervention to maximize adherence to the BecomeAnEX.org smoking cessation pr...

What is the current status of trial NCT02585206?

This trial is currently completed. It is a NA study. The enrollment target is 1,485 participants. The study started on 2018-03-29. Estimated completion is 2020-07-10.

What interventions are being tested in trial NCT02585206?

The interventions under investigation include: Personalization (BEHAVIORAL), Integration (BEHAVIORAL), Dynamic Tailoring (BEHAVIORAL), Message Intensity (BEHAVIORAL), Optimal-Adherence Text (BEHAVIORAL).

Who is sponsoring clinical trial NCT02585206?

This trial is sponsored by Truth Initiative, which has 9 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.